Clinical Trials
26 trialsNCT01408407 2026-05-14
Alkagin Paste in the Prevention of Radiation Dermatitis
Sir Mortimer B. Davis - Jewish General Hospital
Phase 2 Terminated
NCT04234113 2026-03-27
Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors
Sotio Biotech Inc.
Phase 1 Terminated
NCT05551117 2026-02-09
Tamarack
MacroGenics
Phase 2 Terminated
NCT02408861 2026-01-21
Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
National Cancer Institute (NCI)
Phase 1 Terminated
NCT02885142 2025-11-18
MUCEM
Assistance Publique Hopitaux De Marseille
Phase NA Terminated
NCT04272034 2025-10-16
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors
Incyte Corporation
Phase 1 Terminated
NCT03439085 2024-07-09
DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112 and Durvalumab in Treating Patients With Recurrent or Metastatic Human Papillomavirus Associated Cancers
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT04066894 2023-08-14
Sacral Nerve Stimulation in Treating Low Anterior Resection Syndrome or Fecal Incontinence in Patients With Locally Advanced Rectal Cancer or Other Pelvic Cancer, the RESTORE Study
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT04672980 2022-12-08
RTX-321 Monotherapy in Patients With HPV 16+ Tumors
Rubius Therapeutics
Phase 1 Terminated
NCT04596033 2022-07-15
TiTAN-1: Safety, Proliferation and Persistence of GEN-011 Autologous Cell Therapy
Genocea Biosciences, Inc.
Phase 1 Terminated
NCT02503111 2022-06-13
HPV-SAVE
University Health Network, Toronto
Phase NA Terminated
NCT01324141 2021-11-23
Topical MTS-01 for Dermatitis During Radiation and Chemotherapy for Anal Cancer
National Institutes of Health Clinical Center (CC)
Phase 1 Terminated
NCT01249443 2020-07-29
Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
AIDS Malignancy Consortium
Phase 1 Terminated
NCT00568425 2020-06-29
ANAL0002
Stanford University
Terminated
NCT01671488 2020-02-17
276
Brown University
Phase 1/2 Terminated
NCT00955240 2020-02-11
Radiation Therapy, Cisplatin, Fluorouracil, and Cetuximab in Treating Patients With Locally Advanced Anal Cancer
UNICANCER
Phase 2 Terminated
NCT00394602 2020-01-02
Chemoradiation-Induced Nausea and Emesis: Quality of Life
M.D. Anderson Cancer Center
Terminated
NCT03677960 2019-07-24
Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection
Antiva Biosciences
Phase 1 Terminated
NCT02900248 2019-04-02
N1
CureOne
Terminated
NCT00267787 2018-12-10
Molecular Genetic and Pathological Studies of Anal Tumors
Stanford University
Terminated
NCT02407561 2018-01-25
Prospective Validation Study for the Proprietary Rectal and Anal Cancer Protein Expression Assays
Castle Biosciences Incorporated
Terminated
NCT00903396 2017-11-24
Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer
Alliance for Clinical Trials in Oncology
Phase 2 Terminated
NCT00767234 2016-07-11
Permission to Collect Blood Over Time for Research
Stanford University
Terminated
NCT00896467 2013-07-10
Psychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial Therapy
National Cancer Institute (NCI)
Terminated
NCT00068744 2012-09-24
Radiation Therapy, Mitomycin, and Either Fluorouracil or Cisplatin in Treating Patients With Locally Advanced Anal Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2/3 Terminated
NCT00532987 2012-02-28
Assessment of Health Related Quality of Life in Patients Treated for Rectal Cancer
Stanford University
Terminated